Document is current
Any future updates will be listed below
-
Authors
Lu, Benjamin Y. https://orcid.org/0000-0001-8764-8384
Lucca, Liliana E.
Lewis, Wesley
Wang, Jiping
Nogueira, Catarina V.
Heer, Sebastian https://orcid.org/0000-0001-7802-8685
Rayon-Estrada, Violeta
Axisa, Pierre-Paul https://orcid.org/0000-0003-1446-3922
Reeves, Sarah M.
Buitrago-Pocasangre, Nicholas C. https://orcid.org/0000-0002-1333-4435
Pham, Giang H.
Kojima, Mina L. https://orcid.org/0000-0002-3387-8608
Wei, Wei
Aizenbud, Lilach
Bacchiocchi, Antonietta
Zhang, Lin
Walewski, Joseph J.
Chiang, Veronica
Olino, Kelly
Clune, James
Halaban, Ruth https://orcid.org/0000-0001-8451-1964
Kluger, Yuval https://orcid.org/0000-0002-3035-071X
Coyle, Anthony J.
Kisielow, Jan https://orcid.org/0000-0002-4482-5202
Obermair, Franz-Josef https://orcid.org/0000-0002-3918-800X
Kluger, Harriet M.
Hafler, David A. https://orcid.org/0000-0003-4664-535X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA227473, K12 CA215510, R01 CA121974, R01 CA269286, R01 CA227473)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U24 AI11867, R01 AI22220, P01 AI039671)
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (T15 LM007056)
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 24 October 2024
First Online: 28 November 2024
Competing interests
: D.A.H. has received research funding from Bristol-Myers Squibb, Novartis, Sanofi and Genentech. He has been a consultant for Bayer Pharmaceuticals, Repertoire Inc, Bristol-Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno therapeutics, Novartis Pharmaceuticals, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme. H.M.K. has received institutional research grants from Bristol-Myers Squibb, Merck and Apexigen and financial support from Bristol-Myers Squibb, Iovance, Chemocentryx, Signatero, Gigagen, GI Reviewers, Pliant Therapeutics, Esai, Wherewolf and Invox. C.V.N., S.H., A.J.C., J.K. and F.-J.O. are employees and/or stockholders of Repertoire Immune Medicines. S.H., F.-J.O. and J.K. are employees of Repertoire Immune Medicines (Switzerland) AG, formerly Tepthera Ltd. The other authors declare no competing interests.
